Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement: ...

Background Subcutaneous (SC) administration is the preferred parenteral opioid route in palliative care, while intravenous infusion may allow faster titration. Comparative evidence remains limited.

Administering the medications and fluids intravenously is a frequent practice in modern medical procedures, which plays a vital role in the treatment of certain acute conditions which require ...

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment "We are confident that this ...

I’ve endured numerous rounds of radiation and taken thousands of pills—but CAR-T is the most effective therapy I’ve completed ...

The global home infusion therapy devices market is valued at USD 2.6 billion in 2025 and is poised to reach USD 4.8 billion by 2035, registering a CAGR of 6.4%. This growth is expected to be driven by ...

Eastman Schedules Second-Quarter 2025 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast, and Release of Additional Information ...

Not all patients may be suited to epidural analgesia, and so additional options such as intravenous non-opioid analgesic medications that enable a rapid recovery are required. The aim of this review ...

The continued political division and widespread fragilities have hindered the authorities’ capacity to control public expenditure and enact necessary reforms. Unless spending is contained, the fiscal ...

Uzbekistan has made remarkable progress in its transition to a market-oriented economy. Far-reaching economic reforms have transformed the economy and spurred capital inflows which, combined with ...